ABO, ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase, 28
N. diseases: 443; N. variants: 160
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phenotype | Clinical Attribute | 507 | 1037 | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2017 | |||||
|
phenotype | Laboratory Procedure | 32 | 68 | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | |||||
|
phenotype | Laboratory or Test Result | 139 | 296 | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | |||||
|
disease | Neoplastic Process | 860 | 154 | 0.020 | None | 1.000 | 2 | 2006 | 2018 | ||||||
|
disease | Disease or Syndrome | 42 | 28 | 0.020 | None | 1.000 | 2 | 1 | 2013 | 2016 | |||||
|
phenotype | Laboratory Procedure | 15 | 42 | 0.100 | None | 1.000 | 2 | 3 | 2010 | 2019 | |||||
|
phenotype | Laboratory Procedure | 17 | 25 | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2012 | |||||
|
disease | Disease or Syndrome | 632 | 9 | 0.020 | None | 1.000 | 2 | 2017 | 2019 | ||||||
|
disease | Disease or Syndrome | 48 | 35 | 0.020 | None | 1.000 | 2 | 1 | 2016 | 2019 | |||||
|
phenotype | Laboratory Procedure | 2 | 6 | 0.100 | None | 1.000 | 2 | 3 | 2017 | 2019 | |||||
|
phenotype | Laboratory Procedure | 90 | 174 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||
|
phenotype | Diagnostic Procedure | 399 | 1033 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Laboratory Procedure | 681 | 1322 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Laboratory Procedure | 265 | 457 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Clinical Attribute | 430 | 746 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Diagnostic Procedure | 119 | 249 | 0.100 | None | 1.000 | 1 | 5 | 2012 | 2012 | |||||
|
phenotype | Laboratory Procedure | 272 | 452 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 29 | 51 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||
|
group | Laboratory Procedure | 75 | 422 | 0.100 | None | 1.000 | 1 | 35 | 2012 | 2012 | |||||
|
phenotype | Laboratory Procedure | 234 | 474 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
disease | Neoplastic Process | 145 | 9 | 0.010 | None | < 0.001 | 1 | 2017 | 2017 | ||||||
|
phenotype | Sign or Symptom | 42 | 2 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | ||||||
|
phenotype | Laboratory Procedure | 89 | 111 | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | |||||
|
phenotype | Laboratory Procedure | 7 | 10 | 0.100 | None | 1.000 | 1 | 1 | 2008 | 2008 | |||||
|
phenotype | Laboratory Procedure | 269 | 555 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 |